[Determination of individual sensitivity of malignant ovarian neoplasms to antineoplastic drugs].
D000230:Adenocarcinoma / Q000188:drug therapy; D000328:Adult; D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003537:Cystadenoma / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008558:Melphalan / Q000627:therapeutic use; D008875:Middle Aged; D009362:Neoplasm Metastasis / Q000188:drug therapy; D010051:Ovarian Neoplasms / Q000188:drug therapy*; D013438:Sulfhydryl Compounds / Q000378:metabolism; D013844:Thiazoles / Q000627:therapeutic use; D013852:Thiotepa / Q000627:therapeutic use
D000970:Antineoplastic Agents; D013438:Sulfhydryl Compounds; D013844:Thiazoles; D003520:Cyclophosphamide; D013852:Thiotepa; D008558:Melphalan
Vyznachennia indyvidual'noi chutlyvosti zloiakisnykh novoutvoren' iaechnykiv do protyopukhovykh preparativ.